The frequencies of CT expression in the triple-negative (ER-HER2-) carcinomas are similar to the ER-negative group, being 24.0%, 19.1%, 14.2%, 10.2% and 18.2% for MAGEA, NY-ESO-1, CT7, CT10 and CT45, respectively. This evidence concerns the gene MAGEC1 and carcinoma.